Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
JAMA ; 284(13): 1677-82, 2000 Oct 04.
Artículo en Inglés | MEDLINE | ID: mdl-11015798

RESUMEN

CONTEXT: A growing proportion of young children in the United States participate in day care, and these children are considered to be at high risk for influenza infection. Whether vaccinating day care children reduces household transmission of influenza is not known. OBJECTIVE: To evaluate the effect of vaccinating day care children on reducing influenza-related morbidity among their household contacts. DESIGN: Single-blind, randomized controlled trial conducted during the 1996-1997 influenza season. SETTING: Ten day care centers for children of US Navy personnel in San Diego, Calif. PARTICIPANTS: A total of 149 day care attendees (aged 24-60 months) and their families were randomized; 127 children and their 328 household contacts received 2 vaccine doses and were included in the analysis. INTERVENTIONS: Inactivated influenza vaccine was administered to 60 children with 162 household contacts, and hepatitis A vaccine as a control was administered to 67 age-matched children with 166 household contacts. MAIN OUTCOME MEASURES: Information regarding febrile respiratory illnesses and related morbidity for household contacts of influenza-vaccinated vs control children (subgrouped by influenza-vaccinated and unvaccinated contacts), obtained by telephone interviews with parents every 2 weeks from November 1996 through April 1997. RESULTS: Influenza-unvaccinated household contacts (n = 120) of influenza-vaccinated day care children had 42% fewer febrile respiratory illnesses (P =.04) compared with unvaccinated household contacts of control children. Among school-aged household contacts (aged 5-17 years), there was an 80% reduction among contacts of vaccinated children (n = 28) vs contacts of unvaccinated children (n = 31) in febrile respiratory illnesses (P =.01), as well as reductions of more than 70% in school days missed (P =.02), reported earaches (P =.02), physician visits (P =.007), physician-prescribed antibiotics (P =.02), and adults who missed work to take care of ill children (P =.04). CONCLUSIONS: These results indicate that vaccinating day care children against influenza helps reduce influenza-related morbidity among their household contacts, particularly among school-aged contacts. Future studies should be conducted in civilian populations to assess the full effect of vaccinating day care children against influenza. JAMA. 2000;284:1677-1682.


Asunto(s)
Guarderías Infantiles , Transmisión de Enfermedad Infecciosa/prevención & control , Vacunas contra la Influenza , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Adolescente , Adulto , Niño , Preescolar , Composición Familiar , Humanos , Gripe Humana/transmisión , Modelos Logísticos , Morbilidad , Método Simple Ciego , Vacunación
2.
Clin Infect Dis ; 30(2): 356-62, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10671341

RESUMEN

A previous report of nosocomial infection due to Mycobacterium bovis bacille Calmette-Guerin (BCG) implicated contamination of chemotherapy solutions reconstituted under the same biosafety hood as BCG vaccine used for bladder cancer therapy. We report 3 similar BCG infections in children and describe evidence of respiratory transmission to health care workers (HCWs) from 1 patient. These children were receiving chemotherapy for leukemia when they presented with active tuberculosis. Each isolate was identified biochemically and by both gas-liquid chromatography and major polymorphic tandem repeat-polymerase chain reaction. Pulsed-field gel electrophoresis showed that 2 isolates were identical strains and identical to the Tice and Connaught strains licensed in the United States for bladder chemotherapy. The third isolate differed by a single fragment after DraI restriction. One patient with heavily positive sputum exposed numerous HCWs. Of 41 HCWs, 2 (5%) converted their purified protein derivatives (PPD) skin test. These data underscore the risk of nosocomial BCG transmission by contamination of chemotherapy solutions and demonstrate the potential for transmission to HCWs from patients with active pulmonary disease.


Asunto(s)
Infección Hospitalaria/diagnóstico , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Mycobacterium bovis/aislamiento & purificación , Tuberculosis/transmisión , Adolescente , Antineoplásicos/administración & dosificación , Antituberculosos/administración & dosificación , Niño , Preescolar , Electroforesis en Gel de Campo Pulsado , Femenino , Estudios de Seguimiento , Personal de Salud , Humanos , Huésped Inmunocomprometido , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/inmunología , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/inmunología , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico
3.
J Pediatr ; 129(2): 245-50, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8765622

RESUMEN

OBJECTIVE: To evaluate whether pediatric patients infected with human immunodeficiency virus (HIV) can mount appropriate delayed-type hypersensitivity (DTH) skin responses to recall antigens and whether these responses can be correlated with clinical or immunologic parameters. DESIGN: Prospective evaluation of DTH responses in HIV-infected children. Uninfected children born to HIV-infected mothers served as control subjects. Antigens used for yearly DTH testing included Candida albicans (1:100, 1:10); mumps virus; Trichophyton; purified protein derivative of tuberculin; and tetanus toxoid (1:100, 1:10). At the time of each DTH test, patients were staged according to two Centers for Disease Control and Prevention pediatric HIV classification systems, and T-cell subsets were obtained. RESULTS: Twenty-seven HIV-infected patients with a median age at entry of 74.1 (range, 12 to 156) months were followed. Forty-four DTH skin tests in 21 symptom-free HIV-infected patients (PI) and 18 tests in 10 HIV-infected patients with symptoms (P2), as well as 43 DTH skin tests in 18 patients who had either mild or moderate clinical symptoms or immunosuppression and 19 tests in 13 patients with severe symptoms or immunosuppression, were evaluated. Sixteen DTH skin tests were performed in 14 uninfected patients. HIV-infected patients tended to have fewer DTH responses to antigens and of smaller size than did uninfected patients. When controlled for age, few differences in DTH responsiveness were seen between HIV-infected and uninfected patients. Anergy was associated with symptomatic disease, evidence of advanced clinical or immunologic disease, and low CD4+ percentages (p <0.05). CONCLUSIONS: HIV-infected children are able to mount antigen-specific cell-mediated immune responses that are qualitatively similar to those of age-matched control subjects. Loss of DTH responsiveness correlates with both clinical and immunologic evidence of HIV disease progression.


Asunto(s)
Infecciones por VIH/inmunología , Hipersensibilidad Tardía/inmunología , Pruebas Cutáneas , Piel/inmunología , Adolescente , Factores de Edad , Antígenos/inmunología , Antígenos Fúngicos/inmunología , Antígenos Virales/inmunología , Recuento de Linfocito CD4 , Candida albicans/inmunología , Estudios de Casos y Controles , Niño , Preescolar , Estudios de Seguimiento , Humanos , Huésped Inmunocomprometido , Memoria Inmunológica , Lactante , Recuento de Linfocitos , Virus de la Parotiditis/inmunología , Estudios Prospectivos , Subgrupos de Linfocitos T/patología , Toxoide Tetánico , Trichophyton/inmunología , Tuberculina
4.
Clin Pediatr (Phila) ; 34(3): 146-50, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7774141

RESUMEN

We report two cases of Moraxella catarrhalis (M. catarrhalis) bacteremia in apparently healthy children. One patient had bilateral otitis media and the other had pharyngitis and sinusitis; both patients had uncomplicated clinical courses. A literature review revealed 22 reported cases of M. catarrhalis bacteremia in children, 14 (63%) of which occurred in patients who had no identified underlying condition. Eight (36%) cases were seen in children who were immunocompromised. Nine (40%) patients presented with either purpura, petechia, or a maculopapular rash. M. catarrhalis is well known as a respiratory pathogen, but it has not been recognized as a common cause of unsuspected bacteremia in children.


Asunto(s)
Bacteriemia/microbiología , Moraxella catarrhalis/patogenicidad , Infecciones por Neisseriaceae/microbiología , Antibacterianos , Bacteriemia/tratamiento farmacológico , Quimioterapia Combinada/administración & dosificación , Femenino , Humanos , Lactante , Masculino , Moraxella catarrhalis/aislamiento & purificación , Infecciones por Neisseriaceae/tratamiento farmacológico
6.
Pediatr Nephrol ; 8(2): 211-3, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8018501

RESUMEN

Hemolytic uremic syndrome associated with infection by neuraminidase-producing Streptococcus pneumoniae usually presents with fulminant pneumonia and has a high mortality rate. Post-pneumococcal hemolytic uremic syndrome may occur earlier in life than classical hemolytic uremic syndrome. We describe an 18-month-old male with hemolytic uremic syndrome, S. pneumoniae pneumonia, and T-antigen activation characteristic of neuraminidase activity. We have summarized the features of this case and 11 previously reported children. As the use of blood products containing IgM may aggravate this disorder, early recognition of hemolytic uremic syndrome associated with S. pneumoniae neuraminidase production may lead to improved patient outcome through the judicious use of blood products.


Asunto(s)
Bacteriemia/complicaciones , Síndrome Hemolítico-Urémico/diagnóstico , Síndrome Hemolítico-Urémico/etiología , Neumonía Neumocócica/complicaciones , Pruebas de Aglutinación , Antígenos de Carbohidratos Asociados a Tumores/análisis , Prueba de Coombs , Humanos , Lactante , Isoantígenos/análisis , Masculino , Neuraminidasa/metabolismo , Neumonía Neumocócica/diagnóstico , Streptococcus pneumoniae/enzimología
7.
Pediatr Infect Dis J ; 13(3): 177-82, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8177623

RESUMEN

Enteroviruses are common causes of localized and systemic infection in patients of all ages and are the most frequent cause of epidemic aseptic meningitis in the United States. We have developed a polymerase chain reaction (PCR) assay of cerebrospinal fluid (CSF) for rapid diagnosis of enteroviral meningitis. This assay was applied to 257 CSF specimens during a large community outbreak of enterovirus disease; 109 (97%) of 112 enterovirus culture-positive CSF samples contained enterovirus RNA. In addition 35 (66%) of 53 samples from patients with suspected central nervous system disease with negative or no CSF viral cultures were positive by enterovirus PCR. The enterovirus PCR detected 13 different enterovirus serotypes. PCR results are available within 24 hours compared with a mean of 6.8 days for enterovirus culture. The clinical characteristics of 141 patients with enterovirus central nervous system disease are presented. This study demonstrates the usefulness of enterovirus PCR for the rapid diagnosis of enterovirus central nervous system disease and the potential for PCR tests to shorten hospitalization.


Asunto(s)
Brotes de Enfermedades , Infecciones por Enterovirus/líquido cefalorraquídeo , Enterovirus/aislamiento & purificación , Meningitis Viral/líquido cefalorraquídeo , Reacción en Cadena de la Polimerasa , Secuencia de Bases , Niño , Preescolar , Enterovirus/clasificación , Infecciones por Enterovirus/diagnóstico , Infecciones por Enterovirus/epidemiología , Humanos , Lactante , Recién Nacido , Meningitis Viral/diagnóstico , Meningitis Viral/epidemiología , Datos de Secuencia Molecular , Sondas de Oligonucleótidos , ARN Viral/líquido cefalorraquídeo , Serotipificación
10.
Clin Pediatr (Phila) ; 32(8): 467-71, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8403745

RESUMEN

Although blood cultures remain the most specific indicator of Group B streptococcus (GBS) sepsis, a potentially life-threatening infection in neonates, test results may not be available for 24 to 48 hours. Detection of GBS antigen in the urine by latex particle agglutination (LPA) may speed diagnosis. This study analyzed the sensitivity of the GBS urine LPA assay under clinical conditions. The urine of neonates with early-onset GBS bacteremia was analyzed for GBS antigen over a three-year period at six military medical centers. Overall, 53.5% (38/71) of infants with positive blood cultures had a positive urine LPA test. Only one medical center routinely followed manufacturer's recommendations to concentrate urine specimens before testing. These data suggest that the sensitivity for the urine LPA assay, when performed on unconcentrated urine, is lower than previously reported. Clinicians should insist that the laboratory maximize sensitivity by concentrating urine prior to GBS LPA testing.


Asunto(s)
Antígenos Bacterianos/orina , Bacteriemia/inmunología , Pruebas de Fijación de Látex , Infecciones Estreptocócicas/inmunología , Streptococcus agalactiae/inmunología , Antígenos Bacterianos/sangre , Bacteriemia/clasificación , Bacteriemia/orina , Reacciones Falso Negativas , Femenino , Humanos , Recién Nacido , Pruebas de Fijación de Látex/métodos , Masculino , Factores de Riesgo , Sensibilidad y Especificidad , Infecciones Estreptocócicas/sangre , Infecciones Estreptocócicas/clasificación , Infecciones Estreptocócicas/orina
11.
Clin Infect Dis ; 17(1): 123-5, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8102556

RESUMEN

Values for CD4+ lymphocytes are reported to vary by age. We evaluated an ethnically diverse population of healthy children at risk for human immunodeficiency virus infection to establish normal ranges for age-adjusted CD4+ lymphocyte parameters. We identified a threshold of approximately 30% CD4+ lymphocytes which corresponded to a 5th percentile for all ages. It is important that no significant differences in absolute CD4+ lymphocyte counts on the basis of ethnic group were found.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Factores de Edad , Relación CD4-CD8 , Niño , Preescolar , Infecciones por VIH/etiología , Humanos , Lactante , Recuento de Leucocitos , Valores de Referencia , Factores de Riesgo
12.
J Perinatol ; 13(3): 212-6, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8345385

RESUMEN

Early-onset group B streptococci (GBS-EOS) sepsis may be prevented by intrapartum antibiotics administered for GBS maternal colonization, premature labor, or prolonged rupture of membranes. We sought to identify cases of neonatal GBS sepsis after apparent failure of intrapartum chemotherapy and to determine the factors associated with failure of intrapartum antibiotics in these cases. We identified 96 GBS blood culture-positive infants at five military medical centers from 1987 to 1990. Eighteen (18.7%) of these infants had mothers who had received intrapartum antibiotics; 16 of 18 cases were early-onset disease, 15 of which initially had symptoms at less than 1 hour of age. Two infants had late-onset disease develop at 3 weeks of age. At least one perinatal risk factor (prematurity, prolonged rupture of membranes > 12 hours, maternal fever) was present in each of the 16 cases. Indications for intrapartum antibiotics were suspected chorioamnionitis (13 cases), GBS colonization and prolonged rupture of membranes or prematurity (3), and GBS colonization alone (2). Maternal antibiotics included ampicillin (14 cases), cephadyl (1), vancomycin (1), clindamycin (1), and gentamicin alone (1). The median number of doses of ampicillin before delivery was 1 (range, 1 to 21), which was administered at a median of 4 hours (range, 1 to 84) before birth. The mean dose of ampicillin was 1.8 gm/dose (range, 1 to 2 gm/dose). Two of 16 (12.5%) infants with GBS-EOS died as a result of GBS sepsis. In our population of neonates with GBS-EOS, 18.4% (16 of 87) of the infants had positive blood cultures despite intrapartum antibiotics. Intrapartum antibiotics may fail to prevent GBS sepsis in a number of infants born to mothers colonized with GBS or to those with acute chorioamnionitis.


Asunto(s)
Ampicilina/uso terapéutico , Corioamnionitis/tratamiento farmacológico , Rotura Prematura de Membranas Fetales/tratamiento farmacológico , Trabajo de Parto , Infecciones Estreptocócicas/prevención & control , Streptococcus agalactiae/aislamiento & purificación , Ampicilina/administración & dosificación , Femenino , Humanos , Recién Nacido , Embarazo , Factores de Riesgo , Infecciones Estreptocócicas/epidemiología , Insuficiencia del Tratamiento
13.
Pediatr Infect Dis J ; 12(4): 326-9, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8483627

RESUMEN

During two outbreaks of respiratory syncytial virus (RSV) infection, 68 children with acute respiratory illnesses were cultured for RSV using a Rhino-Probe (RP) nasal curette and either a nasopharyngeal (NP) swab or a nasal wash (NW). In the first outbreak isolations of RSV by the RP nasal curette and NP swab methods were compared. RSV was cultured from 25 of 42 (60%) subjects using the RP nasal curette and from 20 of 42 (48%) subjects using the NP swab. In the second outbreak the RP nasal curette and the NW collection techniques were compared. RSV was isolated from 15 of 26 (58%) children evaluated. RSV was cultured from 14 of 15 (93%) patients by RP and 13 of 15 (87%) when using NW. In the group of culture-positive subjects, the TESTPACK RSV rapid antigen test was positive in 10 of 15 (67%) using the RP and in 6 of 15 (40%) using the NW. Like the NP swab the RP nasal curette was simple, noninvasive and relatively inexpensive, yet it was as sensitive as the NW for detection of RSV.


Asunto(s)
Virus Sincitiales Respiratorios/aislamiento & purificación , Infecciones del Sistema Respiratorio/microbiología , Infecciones por Respirovirus/diagnóstico , Manejo de Especímenes/instrumentación , Enfermedad Aguda , Brotes de Enfermedades , Femenino , Humanos , Lactante , Recién Nacido , Masculino
14.
Medicine (Baltimore) ; 72(1): 11-37, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8426535

RESUMEN

We have presented 73 patients (48 adults and 25 children) with microbiologically documented M. bovis infections identified over the 12-year period from 1980 through 1991. Epidemiologic investigation of these patients revealed that the majority (80%) were of Hispanic origin. The non-Hispanic patients either had traveled extensively outside the United States, were born in the United States during its endemic period or in other countries with endemic bovine tuberculosis, or were exposed to a close relative with a positive PPD and known exposure to M. bovis. For Hispanic patients, the presence of reactivation disease in adults and primary disease in children indicate that this mycobacterium remains endemic in Mexican beef and dairy herds, a position supported by United States monitoring of Mexican cattle transferred across the border. Our review of the historical and contemporary efforts to eradicate this animal and human pathogen from the livestock industry in the United States and abroad shows that the implementation of similar methods could be effective in Mexico. The detailed presentations of selected patients and summaries of the clinical manifestations in the remainder of our 73 patients reveal striking similarities to historical accounts and to more contemporary studies of reactivated disease in England. Although M. bovis infections are still expressed predominantly in extrapulmonary sites (cervical and mesenteric nodes, the peritoneum, and the GU tract), as many as 50% of adult patients will present only with pulmonary disease. Underlying immunosuppressive disorders were particularly prominent in adults with extrapulmonary disease. For example, HIV positive patients accounted for 12 of 48 adults and 1 adolescent patient in our series. Overall, M. bovis infections accounted for almost 3% of all tuberculous disease reported in San Diego County during the study period. The intrinsic resistance of M. bovis to PZA could threaten the response of patients with bovine tuberculosis to the short-course chemotherapeutic regimens now recommended by the CDC and the American Thoracic Society. We strongly recommend continued surveillance for this forgotten pathogen because the importation of Mexican cattle, the migration of Hispanic immigrants from border areas to the United States interior, and the persistence of extrapulmonary disease in immunocompetent and HIV-infected United States citizens assure its persistence in this country.


Asunto(s)
Mycobacterium bovis , Tuberculosis/etiología , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Síndrome de Inmunodeficiencia Adquirida/etnología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , California/epidemiología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , México/etnología , Persona de Mediana Edad , Tuberculosis/complicaciones , Tuberculosis/microbiología
16.
Ophthalmology ; 99(2): 246-9, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1553216

RESUMEN

Cat scratch disease is a subacute regional lymphadenitis usually preceded by a history of being scratched by a cat or young kitten. The spectrum of illness ranges from mild self-limited adenopathy to severe systemic disease, including hepatosplenomegaly, encephalopathy, osteolytic lesions, splenic abscesses, mediastinal masses, and neuroretinitis. Vision loss is a rare complication of the disease. The authors report a patient with cat scratch disease associated with acute febrile illness, lymphocytic meningitis, and acute vision loss secondary to neuroretinitis. To their knowledge, this is the first ophthalmic case reported in which the diagnosis is supported by both a positive skin test and positive histopathology.


Asunto(s)
Enfermedad por Rasguño de Gato/complicaciones , Neuritis Óptica/etiología , Retinitis/etiología , Enfermedad por Rasguño de Gato/diagnóstico , Enfermedad por Rasguño de Gato/tratamiento farmacológico , Niño , Dexametasona/uso terapéutico , Femenino , Fondo de Ojo , Humanos , Neuritis Óptica/diagnóstico , Neuritis Óptica/tratamiento farmacológico , Retinitis/diagnóstico , Retinitis/tratamiento farmacológico , Pruebas Cutáneas , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico , Trastornos de la Visión/etiología , Agudeza Visual
18.
Pediatr Infect Dis J ; 9(8): 539-43, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2235168

RESUMEN

The medical records of 30 children with central nervous system tuberculosis (CNS tuberculosis) who were treated between March, 1976, and February, 1989, were reviewed. All had cranial computerized tomography scans at presentation. The mean cerebrospinal fluid leukocyte count was 200/mm3, protein 239 mg/dl, glucose 25 mg/dl and CSF/serum glucose ratio 21%. Mantoux skin tests with 5 tuberculin units were greater than or equal to 10 mm induration in 50%, and chest radiographs were positive in 40% of patients. Hydrocephalus was demonstrated by cranial computerized tomography in all 30 patients (100%). Cranial computerized tomography scan demonstrating hydrocephalus is a sensitive radiographic nervous system tuberculosis and should be part of the early evaluation of children with suspected central nervous system tuberculosis.


Asunto(s)
Encefalopatías/diagnóstico , Hidrocefalia/complicaciones , Tuberculosis/diagnóstico , Preescolar , Farmacorresistencia Microbiana , Etnicidad , Femenino , Humanos , Hidrocefalia/diagnóstico por imagen , Hidrocefalia/tratamiento farmacológico , Lactante , Isoniazida/uso terapéutico , Recuento de Leucocitos , Masculino , Cintigrafía , Tomografía Computarizada por Rayos X , Prueba de Tuberculina , Tuberculosis Meníngea/diagnóstico por imagen , Tuberculosis Meníngea/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA